Ex Parte JUNE - Page 15




              Appeal No. 1999-1245                                                                                     
              Application No. 08/245,282                                                                               


                     expectation of success in view of the teachings of Ward et al. (EJI, 1993),                       
                     using known chemical compounds, for their known intended use.                                     
                            Accordingly, the modification of Ward (1993) by modulating the                             
                     production of  D-3 phosphoinositides by the addition of chemical agents                           
                     as suggested by Vandenberghe and Ward (1992) in order to obtain a                                 
                     method for modulating the response of T cells expressing a CD28 cell                              
                     surface receptor was within the ordinary skill  in the art at the time the                        
                     claimed invention was made.   From the teachings of the references, it is                         
                     apparent that one of ordinary skill in the art would have had a reasonable                        
                     expectation of success in producing the claimed invention.   Therefore,                           
                     the invention as a whole is prima facie obvious, as evidenced by the                              
                     references, especially in the absence of evidence to the contrary.                                
                     As to claim 49, the examiner further finds that                                                   
                     Okada discloses that wortmannin inhibits PI 3-kinases activity and                                
                     that PI 3-kinase activity is involved in the regulation of cell proliferation.                    
                     In view of the teachings of Okada regarding the ability of wortmannin to                          
                     inhibit PI 3-kinases, it would have been obvious to one of ordinary skill in                      
                     the art to modify the method of Ward (EJI, 1993) and Vandenberghe by                              
                     the addition of wortmannin since one of ordinary skill would have the                             
                     reasonable expectation that wortmannin would also inhibit PI 3-kinase                             
                     activity in activated T cells, lacking evidence to the contrary.                                  
                            Accordingly, the modification of the method of Ward et al. (EJI,                           
                     1993) and Vandenberghe by the addition of wortmannin as suggested by                              
                     Okada in order to obtain a method of modulating the response of T cells                           
                     expressing a cell surface receptor was within the ordinary skill in the art at                    
                     the time the claimed invention was made.   From the teachings of the                              
                     references it is apparent that one of ordinary skill in the art would have                        
                     had a reasonable expectation of success in producing the claimed                                  
                     invention.  Therefore, the invention as a whole is prima facie obvious.                           

                     We find the examiner has not established a prima facie case of obviousness on                     
              the record before us, or that the cited references both suggest the claimed subject                      


                                                          15                                                           





Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007